Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora

Medical Mycology

Volumn 48, Issue 2, 2010, Pages 390-393

  Najafzadeh, M J ^a,b,c   Rezusta, A ^d   Cameo, M I ^d   Zubiri, M L ^e   Yus, M C ^e   Badali, H ^a,b   Revillo, M J ^d   De Hoog, G S ^a,b  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Hospital Miguel Servet   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Chromoblastomycosis; Fonsecaea monophora; Itraconazole

Indexed keywords

ACTIN; BETA TUBULIN; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE;

AGED; ANTIMICROBIAL THERAPY; ARTICLE; CASE REPORT; CHROMOMYCOSIS; CLINICAL FEATURE; DISEASE DURATION; DNA SEQUENCE; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FONSECAEA; FONSECAEA MONOPHORA; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSCOPY; NUCLEOTIDE SEQUENCE; RELAPSE; SEQUENCE ANALYSIS; SKIN DEFECT; SKIN NODULE; TISSUE STRUCTURE; TREATMENT DURATION;

FONSECAEA MONOPHORA;

EID: 84928591181     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903008813     Document Type: Article

References (31)

1. Queiroz-Telles F, Esterre P, Perez-Blanco M, et al.. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol 2009; 47: 3-15 .
2. López Martínez R, Méndez Tovar LJ.. Chromoblastomycosis. Dermatol Clin 2007; 25: 188-194 .
3. de Hoog GS, Attili-Angelis D, Vicente VA, et al.. Molecular ecology and pathogenic potential of Fonsecaea species . Med Mycol 2004; 42: 405-416 .
4. Xi L, Sun J, Lu S, et al. Molecular diversity of Fonsecaea causing chromoblastomycosis in southern China. Med Mycol 2009; 27-33 .
5. Badali H, Gueidan C, Najafzadeh MJ, et al. Biodiversity of the genus Cladophialophora . Stud Mycol 2008; 61: 175-191 .
6. Hofmann H, Choi SM, Wilsmann-Theis D, et al. Invasive chromoblastomycosis and sinusitis dueto Phialophora verrucosa in a child from northern Africa. Mycoses 2005; 48: 456-461 .
7. Gugnani HC, Egere JU, Suseelan AV, et al. Chromomycosis caused by Phialophora pedrosoi in eastern Nigeria. J Trop Med Hyg 1978; 81: 208-210 .
8. Arango M, Jaramillo C, Cortes A, et al. Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa . Med Mycol 1998; 36: 43-45 .
9. Marques SG, Pedrozo Silva CM, Resende MA, Andreata LS, Costa JM. Chromoblastomycosis caused by Rhinocladiella aquaspersa . Med Mycol 2004; 42: 261-265 .
10. Queiroz-Telles F, McGinnis MR, Salkin I, et al. Subcutaneous mycoses. Infect Dis Clin N Amer 2003; 17: 59-85 .
11. Padhye AA, Ajello L. A case of chromoblastomycosis with special referenceto the mycology of the isolated Exophiala jeanselmei . Mykosen 1987; 30: 134 .
12. Salgado CG, Da Silva JP, Diniz JAP, et al. Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica , a probable natural source of chromoblastomycosis. Revta Inst Med Trop S Paulo 2004; 46: 33-36 .
13. De Hoog GS, Nishikaku AS, Fernández-Zeppenfeldt G, et al. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol 2007; 58: 219-234 .
14. de Hoog GS, Guarro J, Gené J, Figueras MJ, Atlas of Clinical Fungi , 2nd edn . Utrecht/Reus : Centraalbureau voor Schimmelcultures/ Universitat Rovira i Virgili , 2000 .
15. Carrión AL. Chromoblastomycosis. Ann N Y Acad Sci 1950; 50: 1255-1282 .
16. Najafzadeh MJ, Gueidan C, Badali H, et al. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea . Med Mycol 2009; 47: 17-25 .
17. Surash S, Tyagi A, De Hoog GS, et al.. Cerebral phaeohyphomycosis caused by Fonsecaea monophora . Med Mycol 2006; 43: 465-472 .
18. Zhang J, Xi L, Lu C, et al.. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora : a report of three cases in Guangdong, China. Mycoses 2009; 52: 176-181 .
19. Yaguchi T, Tanaka R, Nishimura K, et al. Molecular phylogenetics of strains morphologically identified as Fonsecaea pedrosoi from clinical specimens. Mycoses 2007; 50: 255-260 .
20. Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001; 44: 1-7 .
21. Jayalakshmi P, Looi LM, Soo-Hoo TS. Chromoblastomycosis in Malaysia. Mycopathologia 1990; 109: 27-31 .
22. Davila SC, Pagliari C, Duarte MI. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia 2002; 156: 51-60 .
23. Vicente VA, Attili-Angelis D, Pie MR. Environmental isolation of black yeast-like fungi involved in human infection. Stud Mycol 2008; 61: 137-144 .
24. Vitale RG, Perez-Blanco M, De Hoog GS. In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis. Med Mycol 2009; 47: 35-40 .
25. Kumar B, Kaur I, Chakrabarti A, et al. Treatment of deep mycoses with itraconazole. Mycopathologia 1991; 115: 169-174 .
26. Restrepo A, Gonzales A, Gomez I, et al.. Treatment of chromoblastomycosis with itraconazole. Ann NY Acad Sci 1988; 544: 504-516 .
27. Borelli D. A clinical trial of itraconazole in thetreatment of deep mycoses and leishmaniasis. Revta Infect Dis 1987; 9: ( Suppl. 1) : S57-S63 .
28. Castro Luiz GM, Pimentel Eugênio RA, Lacaz CS. Treatment of chromomycosis by cryosurgery with liquid nitrogen: 15 years' experience. Int J Dermatol 2003; 42: 408-412 .
29. Kullavanijaya P, Rojanavanich V. Successful treatment of chromoblastomycosis dueto Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. Int J Dermatol 1995; 34: 804-807 .
30. Negroni R, Tobón A, Bustamante B, et al.. Posaconazoletreatment of refractory eumycetoma and chromoblastomycosis. Revta Inst Med Trop S Paulo 2005; 47: 339-346 .
31. Esterrea P, Queiroz-Telles F. Management of chromoblastomycosis: novel perspectives. Curr Opin Infect Dis 2006; 19: 148-152 .